Genmab — Marts 2021
-
God morgen.
-
Asien: Dyk i Tokyo og Hongkong men store regionelle forskelle https://www.proinvestor.com/investornyt/672845/asien-dyk-i-tokyo-og-hongkong-men-store-regionelle-forskelle
-
Mandagens aviser med Ørsted, Schouw & Co. og Genmab https://www.proinvestor.com/investornyt/672844/mandagens-aviser-med-orsted-schouw-co-og-genmab
-
I JP diskuteres over 2 sider primært hvorfor, atkien er ramt så markant her i markedsuroen. 3 faktorer nævnes TVM af cash flow ifht stigende rente, markant øgede omkostninger og usikkerheden omkring udfald af JJ voldgiften
-
Sjovt nok mener artiklen at aktien indeholder stort potentiale for fremtidige stigninger og der er mulighed for yderligere fald...
-
skarp analyse
-
Jep - den kommer hele vejen rundt...
-
Aktier/tendens: Plus i vente og fokus på Bavarian, Vestas og Coloplast
https://www.proinvestor.com/investornyt/672856/aktier-tendens-plus-i-vente-og-fokus-pa-bavarian-vestas-og-coloplast -
Godmorgen - kan der mon leveres et link til artiklen i JP?
-
Er der nogen, der ligger inde med dara recepttal for Jan og Feb?
-
Roche withdrawing the US indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder cancer) https://www.roche.com/investors/updates/inv-update-2021-03-08b.htm
-
Accumulated under the program 27,000 https://www.globenewswire.com/fr/news-release/2021/03/08/2188372/0/en/Transactions-in-connection-with-share-buy-back-program.html
-
Begynder dagens kursudvikling ikke at ligne noget, vi kender?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind